MedPath

Efficacy of 308-nm Excimer Laser for Primary Localized Cutaneous Amyloidosis Treatment in Asians

Not Applicable
Conditions
Lichen Amyloidosis
Interventions
Radiation: 308-nm excimer laser
Registration Number
NCT03068156
Lead Sponsor
Chulalongkorn University
Brief Summary

Efficacy of 308-nm excimer laser for primary localized cutaneous amyloidosis treatment in Asians, pilot study.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Patients, aged >18 years old with lichen amyloidosis diagnosed by using clinical presentation and pathologic features
Exclusion Criteria
  • Those with cutaneous amyloidosis associated systemic diseases
  • Pregnancy or lactating woman
  • Those who are allergic to urea, olive oil
  • Those who are photosensitive to ultraviolet radiation
  • Those who had been previously treated with medications/ radiation/ laser within 3 months for systemic and 1 month for topical therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
excimer laser308-nm excimer laser-
Primary Outcome Measures
NameTimeMethod
Roughness evaluation by using Visioscan® VC98Change from baseline roughness at every 2 weeks up to 16 weeks

The improvement of roughness evaluation

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

King Chulalongkorn Memorial Hospital

🇹🇭

Bangkok, Thailand

© Copyright 2025. All Rights Reserved by MedPath